glp1
Saxenda (liraglutide) tracker
Educational reference for Saxenda (liraglutide). Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
13 h
Tmax
11 h
Category
glp1
Saxenda is Novo Nordisk's brand of liraglutide for weight management.
Mechanism
Saxenda is a brand name for liraglutide, a GLP-1 receptor agonist, at the dose used for weight management. See the liraglutide entry for the full mechanism.
Research summary
Saxenda is the liraglutide product approved for chronic weight management (SCALE program). See the liraglutide entry for broader context.
Reported side effects
As a liraglutide product, gastrointestinal effects are most commonly reported; prescribing information includes class warnings. See the liraglutide entry. This is not a complete safety profile.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Saxenda prescribing information / SCALE program · FDA prescribing information (2014)available via DailyMed; see liraglutide entry
References
TrackPep on seurantasovellus. Se tallentaa tekemäsi kirjaukset eikä koskaan suosittele tai laske määriä.